New Drug Application Filed for Antibody-Drug Conjugate
Trastuzumab Emtansine for the Treatment of HER2-Positive Metastatic or Recurrent Breast Cancer
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin | New Drug Applications | Pharmaceuticals